Homœopathy in the treatment of pneumonia and acute bronchitis

Foubister, D.M.

doi:10.1016/s0007-0785(56)80033-1

Cited by 3 publications

(1 citation statement)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[16][17][18] The evidence for the effectiveness of these interventions is unclear, though studies have reported prophylactic effects in diseases such as chikungunya, 19 leptospirosis, 20 meningitis, 21 dengue, 22 and malaria. 23 Encouraging treatment results were also recorded in pneumonia, [24][25][26][27][28][29] cholera, 30 influenza (Spanish flu 1918, 31 swine flu 2009 32 ), influenza-like illness, 33 dengue, 34 and acute encephalitis syndrome. 35 Most of these were observational (case reports and cohort studies), with limited experimental studies.…”

Section: Repurposing Of Homeopathic Medicinesmentioning

confidence: 99%

Clinical Repurposing of Medicines is Intrinsic to Homeopathy: Research Initiatives on COVID-19 in India

2021

View full text Add to dashboard Cite

As at mid-October 2020, the coronavirus disease 2019 (COVID-19) pandemic has been continuing on the rise across the globe, including in India. Historically, homeopathy has been used in a number of epidemics/pandemics. The development of homeopathic medicines is approached uniquely through “drug provings” and clinical verification; these two intrinsic processes establish the background for the application of homeopathic medicines, regardless of nosological diagnosis. This article reflects research initiatives on COVID-19 in India and identifies studies listed in the Clinical Trial Registry–India database. We identified 29 studies being undertaken in different settings, including those in conventional medicine: 20 randomized controlled trials (RCTs) and 9 observational studies. Fifteen studies are aimed at prophylaxis and 14 are aimed at treatment. Amongst the treatment studies, 11 are focused on efficacy or comparative effectiveness. The findings might provide evidence for clinically repurposing some of homeopathy's medicines, an approach that is intrinsic to the therapy, enabling their use in COVID-19 as an adjuvant or stand-alone to help reduce costs and improve patient recovery.

show abstract